Lv et al. found that pirfenidone could alleviate pulmonary fibrosis through regulating TGF-β1-mediated Smad2/3 phosphorylation and Wnt/glycogen synthase kinase-3β (GSK-3β)/β-catenin signaling pathways [26]. Here, GSK3B is linked to pulmonary fibrosis.